Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

6-bromo-4-chloroquinoline preparation method

A technology of chloroquinoline and bromoquinoline, applied in the field of medicinal chemistry, can solve the problems of long process steps, difficult reactions, complicated operations, etc., and achieve the effects of simplifying the reaction process and post-processing process, reducing production costs, and simple operation

Active Publication Date: 2017-02-22
SHANGHAI ZAIQI BIO TECH
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

As described in the follow-up comparative example 1-2, the synthetic process yield of the existing 6-bromo-4-chloroquinoline is only 26-42%, complicated operation, long process steps, difficult reaction, and low economic benefit and environmental protection. bad impact

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • 6-bromo-4-chloroquinoline preparation method
  • 6-bromo-4-chloroquinoline preparation method
  • 6-bromo-4-chloroquinoline preparation method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] The first step: the synthesis of 3-(4-bromoaniline) ethyl acrylate

[0023] 28.51g (290.66mmol) of ethyl propiolate was added to a 1L three-necked flask containing 50g (290.66mol) of 4-bromoaniline and methanol (500ml) under nitrogen protection with stirring, heated to 40°C, and stirred for 48h , TLC detected that after the reaction was completed, the solvent was spin-dried to obtain 3-(4-bromoaniline) ethyl acrylate (78 g, yield 99%) as a crude product which was directly used in the next step.

[0024] The second step: the synthesis of 6-bromoquinolin-4(1H)-one

[0025] Dissolve 78 g of crude 3-(4-bromoaniline) ethyl acrylate in 150 ml of diphenyl ether, and slowly drop it into a 1L three-necked bottle containing diphenyl ether (470 ml) at 200°C. After 2 hours of reaction, the spot of starting material disappeared. The reaction solution was cooled to room temperature, poured into 1500 ml of petroleum ether, left standing overnight and filtered, the filter residue was...

Embodiment 2

[0032] The first step: the synthesis of 3-(4-bromoaniline) ethyl acrylate

[0033] 57.02g (581.32mmol) of ethyl propiolate was added to a 1L three-necked flask containing 50g (290.66mol) of 4-bromoaniline and methanol (500ml) under nitrogen protection with stirring, heated to 30°C, and stirred for 72h , TLC detected that after the reaction was completed, the solvent was spin-dried to obtain 3-(4-bromoaniline) ethyl acrylate (80 g, yield 100%) as a crude product which was directly used in the next step.

[0034] The second step: the synthesis of 6-bromoquinolin-4(1H)-one

[0035] Dissolve 80 g of crude 3-(4-bromoaniline) ethyl acrylate in 150 ml of diphenyl ether, and slowly drop it into a 1L three-necked bottle containing diphenyl ether (400 ml) at 220°C. After 10 hours of reaction, the starting point of the spot plate disappeared. The reaction solution was cooled to room temperature, poured into 1500 ml of petroleum ether, left standing overnight and filtered, the filter re...

Embodiment 3

[0041] The first step: the synthesis of 3-(4-bromoaniline) ethyl acrylate

[0042] 42.76g (435.99mmol) of ethyl propiolate was added to a 1L three-necked flask containing 50g (290.66mol) of 4-bromoaniline and methanol (500ml) under nitrogen protection with stirring, heated to 50°C, and stirred for 32h. , TLC detected that after the reaction was completed, the solvent was spin-dried to obtain 3-(4-bromoaniline) ethyl acrylate (80 g, yield 100%) as a crude product which was directly used in the next step.

[0043] The second step: the synthesis of 6-bromoquinolin-4(1H)-one

[0044] Dissolve 80 g of crude 3-(4-bromoaniline) ethyl acrylate in 150 ml of diphenyl ether, and slowly drop it into a 1L three-necked bottle containing diphenyl ether (250 ml) at 220°C. After 2 hours of reaction, the spot of starting material disappeared. The reaction solution was cooled to room temperature, poured into 1500 ml of petroleum ether, left to stand overnight, and filtered. The filter residue ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a 6-bromo-4-chloroquinoline preparation method. 4-bromaniline, ethyl propiolate, phosphorus trichloride and the like are used as raw materials to obtain a target product 6-bromo-4-chloroquinoline through three-step reaction. The 6-bromo-4-chloroquinoline preparation method is convenient and simple in operation and environment friendly, the comprehensive yield is 70% or above and remarkably increased as compared with existing yield which is 26-42%, existing medicine production cost is sharply reduced, and the 6-bromo-4-chloroquinoline preparation method is suitable for industrial mass production.

Description

technical field [0001] The invention belongs to the field of medicinal chemistry, in particular to a preparation method of 6-bromo-4-chloroquinoline. Background technique [0002] Omipalisib (GSK2126458, GSK458) is a highly selective and potent inhibitor of p110α / β / γ / δ and mTORC1 / 2, which is mainly used for the treatment of solid tumors, lymphomas, idiopathic pulmonary fibrosis and Drugs for the treatment of idiopathic pulmonary fibrosis. [0003] 6-Bromo-4-chloroquinoline English name is 6-Bromo-4-chloroquinoline, molecular formula is C 9 H 5 BrClN, an important intermediate of Omipalisib. [0004] Since Omipalisib is currently in the clinical research stage, there are few reports on the synthesis of this drug at home and abroad. [0005] Similarly, as an important intermediate of omipalisib, there are few studies on its synthetic route in the prior art. As described in the subsequent comparative examples 1-2, the existing synthesis process yield of 6-bromo-4-chloroqui...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D215/18
CPCC07D215/18
Inventor 王治国宋艳红田贝贝李世江李超李强
Owner SHANGHAI ZAIQI BIO TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products